Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients.
Galati D, Zanotta S, Capone M, Madonna G, Mallardo D, Romanelli M, Simeone E, Festino L, Sparano F, Azzaro R, De Filippi R, Pinto A, Paulos CM, Ascierto PA.
Galati D, et al. Among authors: paulos cm.
J Transl Med. 2023 May 11;21(1):318. doi: 10.1186/s12967-023-04184-6.
J Transl Med. 2023.
PMID: 37170241
Free PMC article.